Bone scan index (BSI) is an effective quantitative biomarker to determine prognosis in patients with castration-resistant metastatic prostate cancer (CRMPC), according to a new study in the Journal of ...

The Bone Scan Index (BSI) is a methodology used to quantify bone metastases and monitor changes under treatment. However, BSI is manually calculated and is, therefore, tedious and time-consuming to ...